Although there is currently no cure for genetic kidney disease, early identification and proactive treatment can slow the disease’s progression, delaying the need for dialysis and kidney transplants.

This project is investigating whether genomic sequencing can provide more definitive diagnosis – in potentially up to one quarter of patients – and enable more personalised care for children and adults.

Genetic kidney disease affects at least 3% of the Australian population and accounts for around 40% of children and 20% of adults who require dialysis or kidney transplantation.


We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2024 Melbourne Genomics Health Alliance